Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Overactive Bladder in Men: Appropriate Management Through Accurate Diagnosis
November 12, 2007
EDITORIAL OVERVIEW Sender Herschorn, MD, FRCSC, Professor and Chair, Department of Urology, University of Toronto, Toronto, Ontario PANEL Greg Bailly, MD, FRCSC, Department of Urology, Dalhousie University, Halifax, Nova Scotia Kevin V
29th Congress of the Société Internationale d’Urologie (SIU)
Benign Prostatic Hyperplasia: Emerging Findings on Combination Therapeutic Strategies
Paris, France / September 2-6, 2007
Paris - Benign prostatic hyperplasia (BPH) is the most common prostate disorder. Half of all males will have BPH by the time they are 50 years old and the incidence increases with age. Major concerns with this disease are related to surgery...
29th Congress of the Société Internationale d’Urologie
Improving Biopsy Detection and Reducing Prostate Volume
Paris, France / September 2-6, 2007
Paris - The majority of North American men have had a serum prostate-specific antigen test in their lifetime, with half being tested annually, yet more than 17% will be diagnosed with prostate cancer. Moreover, up to 30,000 men will die...
62nd Annual Meeting of the Canadian Urological Association
Optimizing Prostate Health: Implications of PCPT and MTOPS Trials
Quebec City, Quebec / June 24-27, 2007
Quebec City - In order to better manage patients with elevated prostate-specific antigen (PSA) levels, determine which patient with an elevated PSA to biopsy and decide when to prescribe a 5-alpha reductase inhibitor (5ARI) for men at high...
102nd Annual Meeting of the American Urological Association
Strategies to Optimize Prostate Health
Anaheim, California / May 19-24, 2007
Anaheim - Recent studies have provided valuable insight into the management of prostate disease, including benign prostatic hyperplasia (BPH) and the prevention of prostate cancer. BPH is commonly treated with alpha-adrenergic-receptor...
102nd Annual Meeting of the American Urological Association
Managing the Prostate Triad of Lower Urinary Tract Symptoms, Overactive Bladder and Benign Prostatic Hyperplasia
Anaheim, California / May 19-24, 2007
Anaheim - The prevalence and incidence of lower urinary tract symptoms (LUTS) in men increase as men surpass 40 years of age. The burden and impact of LUTS will increase dramatically over the next 50 years, owing to demographic factors that...
102nd Annual Meeting of the American Urological Association
Reducing Prostate Cancer Risk and Improving Prostate Health: More Lessons from the PCPT
Anaheim, California / May 19-24, 2007
Anaheim – In 1985, before the era of prostate-specific antigen (PSA) testing, men had a 9% lifetime risk of a prostate cancer diagnosis. The advent and widespread use of screening tests for PSA revealed the true magnitude and impact of...
22nd Annual European Association of Urology Congress
New Trends in Preserving Prostate Health
Berlin, Germany / March 21-24, 2007
Berlin - Benign prostatic hyperplasia (BPH) affects more than 13% of men over 50 years of age. Malignant processes are also highly prevalent although not all prostate cancers are aggressive; in fact, many patients with prostate cancer die...
22nd European Association of Urology Annual Congress
Targeted Therapy in Advanced Renal Cell Carcinoma: Extending Patients’ Lives
Berlin, Germany / March 21-24, 2007
Berlin - A better understanding of the pathological processes implicated in renal cell carcinoma (RCC) has enabled the development of targeted therapies. Tyrosine kinase inhibitors (TKIs) represent a particularly promising class of...